The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
Oxaliplatin Hospira Slow speech 6
OXALIPLATIN TEVA Loss of consciousness 6
OXALIPLATIN. Acute promyelocytic leukaemia 6
OXALIPLATIN. Anaphylactic reaction 6
OXALIPLATIN. Anaphylactic shock 6
OXALIPLATIN. Circulatory collapse 6
OXALIPLATIN. Gastrointestinal oedema 6
OXALIPLATIN. Gastrointestinal toxicity 6
OXALIPLATIN. Hepatic function abnormal 6
OXALIPLATIN. Hypercalcaemia 6
OXALIPLATIN. Impaired gastric emptying 6
OXALIPLATIN. Intestinal perforation 6
OXALIPLATIN. Neck pain 6
OXALIPLATIN. Pulmonary embolism 6
OXALIPLATIN. Refractory cancer 6
OXALIPLATIN. Rib fracture 6
OXALIPLATIN. Sepsis 6
OXALIPLATIN. Skin exfoliation 6
OXALIPLATIN. Stridor 6
OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION Hyperhidrosis 5

Total Records: 864     Number of Pages: 44